Volume 1 Flashcards
Which of the following statements is false?
a) classic hemorrhagic disease of the newborn rarely occurs if babies receive vitamin K at birth
b) women who are on drugs that impair vitamin K metabolism should receive vitamin K supplementation during pregnancy
c) late hemorrhagic disease of the newborn can occur in both breast and formula fed infants
d) a recent increase in late hemorrhagic disease of the newborn has correlated with increased implementation of oral vitamin K supplementation
c) false - happens almost exclusively in breastfed infants
late HDNB - 50% chance of intracranial hemorrhage
the others
- a) true, classic hemorrhagic disease refers to hemorrhagic disease in 1st week of life
characterized by GI hemorrhage and in some cases intracranial bleeding
b) drugs that impair include warfarin and anticonvulsants, this prevents early HDNB (within 1st 24 hours)
d) in numerous countries including Germany, Australia, Britain, Sweden -> increase at the same time that increase in oral vitamin K use happened, late hemorrhagic disease of the newborn refers to disease between 3-8 weeks of age
historically
1961 - AAP recommended vitamin K1 for neonates 0.5-1 mg IM for all neonates
1988 - CPS said that 2.0 mg PO vitamin K was acceptable alternative ->at the time there were concerns about pain etc. this was before the (since retracted) study suggesting IM vitamin K caused childhood cancer, was released
**now we are revising the suggestions
Which of the following is the timing of presentation for late hemorrhagic disease of the newborn?
a) week 1 of life
b) 3-8 weeks
c) within 6-12 weeks
d) within 1st 24 hours
b) answer is 3-8 weeks for late disease
the others
a) classic - within week 1
d) early - within first 24 hours
**Note this is way different in Nelson
Which of the following is false?
a) IM vitamin K is more effective than oral vitamin K at prevention of HDNB
b) in the first 5 days, both IM and oral vitamin K induce the same levels biochemical indicators of vitamin K deficiency
c) a mixed micelle form of vitamin K may work better than current oral formulations but is likely still not as good as IM vitamin K
d) biochemical indicators of vitamin K deficiency correlate well with the clinical risk of bleeding from HDNB
e) A meta-analysis of cohort studies regarding vitamin K suggests an increased relative risk of up to 13% with oral vitamin K administration
d) false
- problem is that these have poor correlation
the rest are true
a) overall studies
- failure rate 0.25/100 000 vs. 1.4/ 100000 in one epidemiological study from Germany, in countries where oral vitamin K is the norm, incidence of late HDNB varied – 1.5 (Britain), 6.0 (Sweden) and 6.4 (Switzerland) /100000
- some might have underlying vitamin K disorders
- in Canada we don’t know the specific incidence(as of 1997 when statement came out)
b) in the absence of adequate vitamin K, an induced protein PIVKA -II can be measured in the blood, protein disappears by 5 days with 1.0 mg oral vitamin K; at 5 days, no difference between oral and IM vitamin K, however at 4-6 weeks, biochemical signs of vit K deficiency in 19% of babies who received 2.0 mg PO at birth vs. 5.5% of those who received 1.0 mg IM
c) true
e) compared oral with IM - RR 13.82; even when excluding for liver disease (which can’t usually be determined at birth, was 8%
Which of the following infants does not need to be considered for repeated doses of vitamin K?
a) kidney disease
b) chronic diarrhea
c) liver disease
d) failure to thrive
a) not true, the other indications may want to consider repeated doses
breastfed babies more risk of late HDNB from vitamin K deficiency - some have suggested to give lactating mothers vitamin K
one study from Denmark showed that giving repeated doses of oral vitamin K until 3months reduced incidence of late HDNB compared to single oral dose , may not be practical because of poor patient compliance
one epidemiological study: Netherlands, Germany, Switzerland and Australia, three oral doses of 1 mg vitamin K less effective than IM vitamin K, but daily oral dose of 25 mg after an initial dose of 1 mg vitamin K may be as effective
reasons for better benefit from IM vitamin K not clear
vitamin K doesn’t protect completely from HDNB, especially in breastfed infants
consider vitamin K deficiency for any infant with bleeding in 1st 6 months of life
Which of the following is the optimal dose and administration of vitamin K for a 3 kg baby?
a) 0.5 mg vitamin K1 IM within 1st 6 hours
b) 1.0 mg vitamin K1 IM within 1st 6 hours
c) 2.0 mg vitamin K1 IM within 1st 8 hours
d) 2.0 mg vitamin K1 PO within 1st 8 hours
b) 1.0 mg for >1500 g, 0.5 mg for
Which of the following about nitric oxide is false?
a) generated in the vascular muscle cells
b) made from L-arginine by NO synthase enzymes
c) NO diffuses into vascular cells and activates guanylate cyclase
d) NO leads to increased cGMP, pulmonary vasodilation and improved V/Q mismatching
a) false - generated in the lung endothelium
b) NO synthase enzyme
the rest are true
Which of the following is not one of the research findings regarding inhaled nitric oxide
a) improves oxygenation in term infants without significant toxicity
b) reduces incidence of death in PPHN
c) reduces incidence of death CDH
d) reduces need for ECMO
c) false - did not reduce the incidence of death in CDH based on Cochrane study
iNO as a selective pulmonary vasodilator for term newborn infants with hypoxemic respiratory failure and PPHN was introduced in 1992
several reports - improved oxygenation without significant toxicity or effect on systemic circulation
after that, single and multi centre prospective trials of late preterm and term infants showed:
- improved oxygenation
-improved incidence of death and ECMO
Cochrane Systematic review
- iNO at doses 10-80 ppm improves oxygenation as assessed by OI when compared to placebo or standard care
- decreases incidence of death and ECMO in infants with PPHN (mainly through the reduction in ECMO)
-did not reduce the incidence of death in CDH
- iNO no impact on adverse neurodevelopment outcomes although long term effects not studied
-earlier initiation of iNO at OI of 15-25 improved oxygenation but didn’t help with death/ECMO
Which of the following is the correct formula for Oxygenation Index (OI)?
a) [PaO2 x MAP x 100] /FiO2
b) [PaO2 x FiO2 x 100]/MAP
c) {PaO2}/[FiO2 x MAP x 100]
d) [FiO2 x MAP x 100]/PaO2
d) is the answer
remember that it’s how much help they are needing (i.e. FiO2 and MAP) over how successful it is (PaO2)
What are the criteria for using iNO
1) resp failure on max support at GA > or equal to 35 weeks
2) OI>20-25
3) PaO2<100 mmHg on max vent support on 100% O2
b) is one of the criteria, best types of ventilation optimizes Tv and Pressures, consider surfactant, HFO and/or JET to optimize lung recruitment, when you do all this and it still don’t work, consider iNO. ideally - should do an echo to rule out cyanotic heart disease and to assess the pulmonary hypertension and cardiac function in all babies that are candidates for nitric oxide
a) false - usually OI 20-25
c) false - so far, evidence supports use for infants greater than or equal to 35 weeks at birth, with hypoxic respiratory failure not responding to appropriate management
iNO in prems: Cochrane review of 14 trials, conflicted evidence
- overall- does not appear affective as rescue (no effect on reducing mortality or BPD, in sick infants minor increase in IVH/PVL) OR routine treatment (minor reduction in death/BPD for >1000g intubated babies, no increase in IVH/PVL in these less sick babies ) for perms who need assisted ventilation
- routine use in moderately ill >1000g - one study showed reduced CP, another study (non Cochrane) improved neurodevelopment outcomes at 2 years old
- may be beneficial in small number of clinical situations - i.e. respiratory failure with oligohydramnios
Which of the following is the best starting dose of iNO in term newborns?
a) 10 ppm
b) 15 ppm
c) 20 ppm
d) 40 ppm
c) 20 ppm is the answer - has been used from 1-80 ppm, then titrated to desired effect, short half life 2-6 s. doses>40 ppm have increased toxicity without additional benefits
- iNO should be in level 3 NICUs supervised by experienced physicians, should have ECMO and other ventilatory support
- can be used on transport to level 3 NICU
- constant source of iNO gas, can use with conventional, JET or HFO
- very expensive
Which of the following is the expected response from iNO?
a) improvement in PaO2 by >20 mmHg in less than 30 minutes
b) improvement in PaO2 by >10 mmHg in less than 60 minutes
c) improvement in PaO2 by >30 mmHg in less than 30 minutes
d) improvement in PaO2 by >20 mmHg in less than 60 minutes
a) is the answer for the expected response, should be quick. if no response, should increase dose to 40 mmhg
in prems - starting dose was 10 ppm and increased to 20 ppm in non responders, should keep concentration of No2 in mixture as low as possible 0.5 ppm
When is the appropriate time to wean iNO?
a) after improvement in oxygenation, 4-6 hours of stability, with wean to 60-80% FiO2 or OI 50 mmHg consistently)
if you stop too abruptly - can get hypoxia because of down regulation of endogenous NO
if fails wean, then go back to previous dose and wean more slowly over 24-48 hours
generally - in studies, patients on NO for approx 48-92 hours, if you can’t wean in a week then should look for other lung and heart problems
Which of the following is not a potential toxicity of iNO?
a) production of methemoglobin
b) production of NO2
c) increased platelet aggregation
d) surfactant dysfunction
c) DECREASED platelet aggregation and increased risk of bleeding
no severe side effects reported, at starting dose of 20 ppm with increase to 40 ppm, minimal toxicity
NO2 : produced by chemical reaction with O2 in ventilator circuit and airways, is cytotoxic, can cause pulmonary injury at > 5ppm, peak level of NO2 is 0.8 +/- 1.2 ppm, no gas was discontinued due to toxicity; iNO doses at <20 ppm not elevated levels (and remember that for pre terms we start at lower dose of iNO - usually 10 in studies )
Which of the following is not one of the reasons to prevent pain in the neonate?
a) ethical obligation
b) potential neuroanatomical consequences
c) potential behaviour consequences
d) altered pain sensitivity which resolves by adolescence
d) false - altered pain sensitivity is one of the reasons but this does persist into adolescence
can be altered with effective pain relief
the others have been found in animal studies
Which of the following is an appropriate use of pain relief in the NICU?
a) IV fentanyl infusion for the chronically ventilated preterm neonate
b) use of topical anaesthetics for heel stick draws and other procedures
c) use of non nutritive sucking, oral glucose and kangaroo care for minor procedures
d) repeated use of topical anaesthetics for multiple procedures
e) acetaminophen is a good option for post surgical pain in neonates after major surgery
c) other ones are swaddling and developmental care
the rest are false
b) not effective for heel stick draws, should limit use of topical anaesthetics (try not to do too much repeated use) can use them for venipunture and LPS (but don’t use super repeat)
a) not recommended continuous infusion of midas, fentanyl or morphine in this population because of concern of short term side effects and lack of long term data
e) opioids should be used post operatively for major surgery without a regional anaesthesia, use post op analgesia as long as needed based on pain scales, acetaminophen should be used as an adjust to opioids and regional anaesthesia, hard to calculate dosages for
Which is an appropriate pain management for the procedure listed?
a) retinal examination - oral sucrose and local anaesthetic eye drops
b) retinal surgery - oral sucrose and local anaesthetic eye drops
c) chest drain insertion- local anaesthetic into skin
d) chest drain removal - non pharmacological interventions
a) is appropriate - no perfect evidence, but this would be a reasonable approach
the rest are not appropriate
c) local anaesthetic into skin unless life threatening reaction,if inadequate time to put local anaesthetic, putting it in after might help with later pain responses and analgesic requirements, ALSO should have fast acting opiate such as fentanyl
d) should give fast acting systemic analgesic ALSO non pharmacological measures
b) retinal surgery should be considered major surgery and should have pain control with opiates
Which of the following is the criteria for retinopathy of prematurity screening in Canada as per the CPS?
b) is the answer all infants < 30 week 6/7 or <1250 g at birth (at the end it says AND)
based on this, UK and Canada say b) is the best criteria
Which of the following is incorrectly matched ?
a) stage 1: demarkation line separates avascular from vascular retina
b) stage 2: extra retinal fibrovascular proliferation/neonvascularization
c) stage 4: partial retinal detachment
d) plus disease: vascular tortuosity of at least 2 quadrants of the eye
B) FALSE - this is stage 3
the rest are true
retinopathy of prematurity - abnormal development of blood vessels of the preterm infant
stage 1: demarkation line separates avascular from vascular retina
stage 2: ridge arising in area of demarcation line
stage 3: extra retinal fibrovascular proliferation/neonvascularization
stage 4: partial retinal detachment
stage 5: complete retinal detachment
pre-plus disease: more vascular tortuosity than normal but not enough for plus disease
plus disease: vascular tortuosity of at least 2 quadrants of the eye
zone 1,2, and 3 describe the different areas of the retina -see diagram in the statement; zone 3 is lateral, zone 1 is the centre
When should a ex 26 week baby be screened for the first time for ROP?
a) 8 weeks chronological (24 weeks CGA)
b) 6 weeks chronological (32 weeks CGA)
c) 4 weeks chronological (30 weeks CGA)
d) 5 weeks chronological (31 weeks CGA)
d) 31 weeks corrected GA
these guidelines are to detect 99% of infants at risk of poor visual outcome; 1st exam between 4-9 weeks of age depending on GA at birth
more mature infants - screen at 4 weeks for 1st exam
stop screening when no more risk of severe ROP
99% develop by 45 weeks GA
for all
When should an ex 29 week baby be screened for the first time for ROP?
a) 8 weeks chronological (37 weeks CGA)
b) 6 weeks chronological (35 weeks CGA)
c) 4 weeks chronological (33 weeks CGA)
d) 2 weeks chronological (31 weeks CGA)
c) is the answer, for all 27 weeks onwards do at 4 weeks chronological (so corrected CGA increases for each increase in GA at birth)
at the moment, not any clear screening criteria of who is at increased risk for ROP, so can’t modify these guidelines
poor postnatal weight gain as a predictive factor for ROP is being studied and is promising but further confirmation is required
digitalized ROP not yet figured out
Which of the following is false of treatment for ROP?
a) retinal ablation is the basis of treatment using cryotherapy and laser photocoagulation
b) goal is to decrease production of angiogenic factors at the avascular part of the retina
c) intravitreal injection of anti vascular endothelial growth factor antibodies is an effective option
d) even with treatment, there is significant negative outcome for babies with ROP
c) is being studied
Results of the Early Treatment for Treatment of ROP Trial - showed that treatment pre-threshold reduces unfavourable visual acuity and structural outcomes, indications for trial have been refined
Which of the following ROP disease needs to be followed < 1 week
a) stage 1 or 2 ROP in zone 1
b) immature vascularization in zone 1
c) stage 2 ROP in zone 2
d) stage 1 ROP in zone 2
a) needs to be followed one week or less - i remember it as the closer to the optic nerve, the closer the follow up needs to be even if the ROP isn’t as bad
< 1 week follow up: stage 1 or 2 in zone 1, stage 3 ROP in zone 2
1-2 weeks follow up: immature vascularization in zone 1, stage 2 ROP in zone 2, regressing ROP in zone 1 (make sure keeps regressing)
Which of the following ROP diseases need to be followed 2-3 weeks?
a) stage 1 ROP in zone II
b) stage 1-2 ROP in zone 3
c) regressing ROP in zone II
d) regressing ROP in zone 1
b) stage 1-2 ROP in zone 3; again, far away from the optic nerve so less intense follow up
regressing ROP in zone 3 also needs follow up every 2-3 weeks
the others options are 2 week follow up: for stage 1 ROP in zone 2, regressing ROP in zone II, regressing ROP in zone I
Which of the following cases do you not need to consider retinal ablative therapy for?
a) stage 1 ROP in zone 1
b) stage 1 ROP in zone 1 with plus disease
c) stage 3 ROP in zone 1
d) stage 2-3 ROP in zone 2 with plus disease
a) don’t need to consider
consider for pre-threshold retinal ablative therapy are as followed:
zone 1: any stage ROP with plus disease
zone 1: stage 3 ROP with or without plus disease
zone II: stage 2-3 ROP with plus disease
should perform for retinal ablation for all threshold ROP:
- 5 or 8 clock hours of stage 3 ROP in zone 1 or 2 in the presence of plus disease
treatment should be within 72 hours of the examination
Which of the following is not a criteria to stop ROP screening?
a) complete vascularization
b) zone 3 vascularization without previous zone I or II ROP
c) PMA of 40 weeks and no pre-threshold disease or worsening ROP
d) regression of ROP
c) is supposed to be 45 weeks and no pre-threshold disease or worsening ROP
infants with ROP - at risk for poor visual acuity and other visual disturbances regardless of whether they needed treatment; risk of poor visual outcome even with treatment
How long are stored RBCs safe and effective for?
a) 7 days
b) 2 weeks
c) 30 days
d) 42 days
d) safe and effective for up to 42 days, permit the use of donor packs
blood in Canada is now component specific - fresh whole blood no longer available
Which of the following is a concern of blood transfusions particularly in the newborn period?
a) graft vs. host disease
b) CMV infection
c) TRALI
d) hemolytic reaction
b) for newborns - CMV may have very important consequences for newborn babies, chance reduced by universal leukoreduction
the others:
- irradiation - to reduce GVHD (but not common in babies)
- TRALI - not common in babies
- hemolytic - rare, may have maternal antibodies in 1st two months, but babies own unlikely until 6 months of age
adverse reactions:
- infections - risk is 1/1.3 million by viruses
- leucocyte causing acute injury
- acute volume or electrolyte disturbances
-blood group incompatibilities (often error)